Compositions and methods for immunoaffinity purification

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7534861
APP PUB NO 20040138413A1
SERIAL NO

10340179

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A hybrid polypeptide composed of a p53 epitope peptide and a desired functional protein are produced by recombinant DNA techniques. A DNA expression vector is constructed that includes segments of DNA coding for the epitope peptide and the desired functional protein. An optional linking portion is contemplated. The linking portion of the epitope peptide is cleavable at a specific amino acid residue adjacent the functional protein by use of a sequence specific proteolytic enzyme or chemical proteolytic agent. The hybrid polypeptide expressed by the host cells transformed by the cloning vector is removed therefrom and purified by affinity chromatography techniques by use of an immobilized antibody specific to the antigenic portion of the epitope peptide. The protein is then cleaved from the isolated hybrid polypeptide with an appropriate proteolic enzyme or chemical agent, thereby releasing the mature functional protein in highly purified, highly active state.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
AMBERGEN INC313 PLEASANT STREET WATERTOWN MA 02472

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Gite, Sadanand Cambridge, US 20 208
Lim, Mark Reading , US 3 24
Olejnik, Jerzy Allston , US 108 1475
Rothschild, Kenneth J Newton, US 103 1574

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation